Journal article icon

Journal article : Review

Galectin-3 in the Lateral Ventricle Regulates Immune Functions

Abstract:
Galectin-3 (Gal-3) is a protein expressed by glia that belongs to an ancient family. Gal-3 recognises molecular patterns on pathogens due to the high degree of its binding specificity with carbohydrate recognition domains. Thus, in sponges as well as other invertebrates, galectins are an important component of the primitive innate immune system. Whereas Gal-3′s function in driving mammalian inflammation is well known, its function in warding off bacterial and viral infections is not well appreciated. One route of brain infection is via the cerebrospinal fluid brain interface (CSFBI) which is primarily composed of ependymal cells (EC). ECs express high levels of Gal-3, and their motile cilia are compromised in Gal-3 KOs. In this mini-review, we discuss fundamentally important potential roles of Gal-3 in pathogen recognition at the CSFBI and suggest avenues of further study.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Publisher copy:
10.1080/17590914.2026.2622750

Authors

More by this author
Institution:
University of Oxford
Role:
Author
More by this author
Institution:
University of Oxford
Role:
Author
More by this author
Institution:
University of Oxford
Role:
Author


More from this funder
Funder identifier:
10.13039/501100004789
More from this funder
Funder identifier:
https://doi.org/10.13039/501100004789


Publisher:
Taylor and Francis Group
Journal:
ASN Neuro More from this journal
Volume:
18
Issue:
1
Article number:
2622750
Publication date:
2026-12-31
Acceptance date:
2026-01-22
DOI:
EISSN:
1759-0914
ISSN:
1759-0914


Language:
English
Keywords:
Subtype:
Review
Source identifiers:
3756408
Deposit date:
2026-02-13
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP